The 31st Conference on Retroviruses and Opportunistic Infections (CROI), held from March 3 to 6, 2024, is planned as an in-person conference at the Colorado Convention Center in Denver, Colorado. The best and most consequential original research on HIV and related conditions will define the science at the conference. CROI 2024 will also accept important new findings on SARS-CoV-2 and the mpox virus. The in-person conference will also feature innovative interactive sessions, rich poster sessions, and networking opportunities.

The CROI 2024 Program below is preliminary and subject to change. New information will be posted as it becomes available.

8:30 AM MT - 12:30 PM MT
New Investigator Workshop

Scott M. Hammer Workshop for New Investigators and Trainees 

Widely considered the most informative and comprehensive session, this workshop highlights key presentations that will take place during CROI. Although the workshop is directed toward new investigators and trainees (eg, undergraduate students, graduate students, postdoctoral fellows, and physician fellows), all CROI attendees are encouraged to attend. Scholarship recipients are required to attend.
 

2:00 PM PT - 4:00 PM MT
CONCURRENT TECHNICAL WORKSHOPS
  • Frontiers in Laboratory Technologies
  • Case-Based Workshop on the Liver and Its Complications
  • Clinical Trial Design and Analysis
  • Cased-Based Workshop on Antiretroviral Therapy*
    *new this year
5:00 PM MT - 7:20 PM MT
Opening Session

Bernard Fields Lecture

Barney Graham, NIAID Vaccine Research Center, Bethesda, Maryland, USA

The Bernard Fields Lecture recognizes a basic scientist for important and relevant contributions to the fields of virology and viral pathogenesis.

N’Galy-Mann Lecture

Dorothy M’bori-Ngacha, Formerly with United Nations Children’s Fund, Nairobi, Kenya

The N’Galy-Mann Lecture recognizes an HIV/AIDS researcher for important and relevant work in the fields of epidemiology or clinical research.

Martin Delaney

Frank Mugisha, Sexual Minorities Uganda (SMUG), Kampala, Uganda

The Martin Delaney Presentation recognizes the important work of community advocacy and engagement in research.

8:30 AM MT - 9:30 AM MT
MONDAY PLENARY SESSION

What’s New in HIV Vaccines
M. Juliana McElrathFred Hutchinson Cancer Research Center, Seattle, Washington, USA

HPV Elimination in Africa: A Reachable Reality?
Nelly Mugo, Kenya Medical Research Institute, Nairobi, Kenya

10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM MT - 4:00 PM MT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
  • The HIV Vaccine Journey: Don’t Stop Believin’  
  • Living Into Young Adulthood with Perinatal HIV  
  • The Return of Syphilis 
8:30 AM MT - 9:30 AM MT
TUESDAY PLENARY SESSION

Resistance, HIV Assembly, and Maturation Inhibitors
Eric Freed, National Institutes of Health, Bethesda, Maryland, USA

Short-Course Prevention and Treatment of Tuberculosis
Vidya Mave, Center for Infectious Diseases in India, Pune, India

10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM MT - 4:00 PM MT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
  • Not Just a Pretty Shape: HIV Assembly to Disassembly   
  • New Frontiers in Hepatitis B  
  • Roundtable on DoxyPEP: Ready or Not…   
  • Impact on Refugees, Displaced Persons, and Marginalized Populations 
8:30 AM MT - 9:30 AM MT
WEDNESDAY PLENARY SESSION

Long-Acting Treatments for HIV and Beyond
Charles Flexner, The John Hopkins University, Baltimore, Maryland, USA

New Frontiers in Testing: Technologies and Programs
Natika Pai, McGill University, Montreal, Quebec, Canada

10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM MT - 4:00 PM MT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
  • Innovations in Intervention: Toward an HIV Cure
  • Follow Your Heart: Managing Cardiovascular Disease Risk in PWH
  • Perils and Pitfalls of Biomedical Prevention: Beyond Phase III
Sunday, March 3, 2024
8:30 AM MT - 12:30 PM MT
New Investigator Workshop

Scott M. Hammer Workshop for New Investigators and Trainees 

Widely considered the most informative and comprehensive session, this workshop highlights key presentations that will take place during CROI. Although the workshop is directed toward new investigators and trainees (eg, undergraduate students, graduate students, postdoctoral fellows, and physician fellows), all CROI attendees are encouraged to attend. Scholarship recipients are required to attend.
 

2:00 PM PT - 4:00 PM MT
CONCURRENT TECHNICAL WORKSHOPS
  • Frontiers in Laboratory Technologies
  • Case-Based Workshop on the Liver and Its Complications
  • Clinical Trial Design and Analysis
  • Cased-Based Workshop on Antiretroviral Therapy*
    *new this year
5:00 PM MT - 7:20 PM MT
Opening Session

Bernard Fields Lecture

Barney Graham, NIAID Vaccine Research Center, Bethesda, Maryland, USA

The Bernard Fields Lecture recognizes a basic scientist for important and relevant contributions to the fields of virology and viral pathogenesis.

N’Galy-Mann Lecture

Dorothy M’bori-Ngacha, Formerly with United Nations Children’s Fund, Nairobi, Kenya

The N’Galy-Mann Lecture recognizes an HIV/AIDS researcher for important and relevant work in the fields of epidemiology or clinical research.

Martin Delaney

Frank Mugisha, Sexual Minorities Uganda (SMUG), Kampala, Uganda

The Martin Delaney Presentation recognizes the important work of community advocacy and engagement in research.

Monday, March 4, 2024
8:30 AM MT - 9:30 AM MT
MONDAY PLENARY SESSION

What’s New in HIV Vaccines
M. Juliana McElrathFred Hutchinson Cancer Research Center, Seattle, Washington, USA

HPV Elimination in Africa: A Reachable Reality?
Nelly Mugo, Kenya Medical Research Institute, Nairobi, Kenya

10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM MT - 4:00 PM MT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
  • The HIV Vaccine Journey: Don’t Stop Believin’  
  • Living Into Young Adulthood with Perinatal HIV  
  • The Return of Syphilis 
Tuesday, March 5, 2024
8:30 AM MT - 9:30 AM MT
TUESDAY PLENARY SESSION

Resistance, HIV Assembly, and Maturation Inhibitors
Eric Freed, National Institutes of Health, Bethesda, Maryland, USA

Short-Course Prevention and Treatment of Tuberculosis
Vidya Mave, Center for Infectious Diseases in India, Pune, India

10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM MT - 4:00 PM MT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
  • Not Just a Pretty Shape: HIV Assembly to Disassembly   
  • New Frontiers in Hepatitis B  
  • Roundtable on DoxyPEP: Ready or Not…   
  • Impact on Refugees, Displaced Persons, and Marginalized Populations 
Wednesday, March 6, 2024
8:30 AM MT - 9:30 AM MT
WEDNESDAY PLENARY SESSION

Long-Acting Treatments for HIV and Beyond
Charles Flexner, The John Hopkins University, Baltimore, Maryland, USA

New Frontiers in Testing: Technologies and Programs
Natika Pai, McGill University, Montreal, Quebec, Canada

10:00 AM MT - 12:00 PM MT
CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

12:00 PM MT - 1:30 PM MT
Lunch Break for Attendees and New Investigator Networking Sessions
1:30 PM MT - 2:30 PM MT
CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

2:30 PM MT - 4:00 PM MT
POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in person will be assigned to stand at their respective boards, organized by topic, on one of the 3 conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

4:00 PM MT - 5:30 PM MT
CONCURRENT INTERACTIVE SESSIONS AND SYMPOSIA
  • Innovations in Intervention: Toward an HIV Cure
  • Follow Your Heart: Managing Cardiovascular Disease Risk in PWH
  • Perils and Pitfalls of Biomedical Prevention: Beyond Phase III

Last Modified: Aug 17, 2023 @ 3:40 pm